BRANDON EGNER: Open Payments
NPI 1225460298 · WENATCHEE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$158 in 7 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $185 · 2025 $158
Food & beverage: $158
| Company | Payments | Amount |
|---|---|---|
| Koya Medical, Inc. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Abbott Laboratories | 1 | $21 |
| HEARTFLOW, INC. | 1 | $16 |
| Amgen Inc. | 1 | $14 |
Products named: KOYA MEDICAL, LEQVIO, Kerendia, CAMZYOS, AMPLATZER AMULET, FFRct, REPATHA.
Industry payments across WA — which companies pay providers there.
